Health officials in Los Angeles County have confirmed the region’s first fatal overdose tied to cychlorphine, an emerging synthetic opioid that laboratory research suggests may be significantly more potent than fentanyl.
The Los Angeles County Department of Public Health announced Thursday that a fatal overdose in February marked the initial verified appearance of the substance in the local illicit drug supply, The Independent reported. Officials warned that cychlorphine can cause fatal respiratory arrest even in tiny amounts and often circulates without the knowledge of people consuming illicit drugs.
A growing footprint across the country
Chemically known as N-propionitrile chlorphine, the substance belongs to a class of synthetic opioids called orphines. Forensic researchers first detected it in the American illicit supply in 2024, according to the Center for Forensic Science Research and Education. Since then, the drug has surfaced in powders, counterfeit pills, liquids and crystal forms across at least 19 U.S. jurisdictions, federal records show.
Data cited by federal officials linked cychlorphine to at least 55 fatal overdoses nationwide as of early 2026, Yahoo News reported. Regional figures show localized clusters; the Knox County Regional Forensic Center in Tennessee identified 63 fatalities tied to the drug between July 2025 and September 2026, Rolling Stone reported.
Fatalities have also emerged elsewhere in California. In San Francisco, medical examiners determined that a 16-year-old died in April from an overdose involving cychlorphine, prompting an investigation that resulted in multiple arrests and the seizure of more than 20,000 counterfeit pills in September.
In August, the Drug Enforcement Administration placed cychlorphine alongside three related orphine analogues into Schedule I of the Controlled Substances Act, a designation reserved for drugs that carry a high potential for abuse and possess no accepted medical use.
Detection limits and overdose response
Health authorities emphasized that conventional fentanyl test strips cannot register cychlorphine because the strips are chemically designed to recognize only fentanyl. Consequently, people using illicit substances cannot rely on standard test strips to verify the presence of cychlorphine in pills or powders.
In response to the limitation, Los Angeles County officials noted that residents can access specialized drug checking services through local public health programs that produce results within 20 minutes.
Laboratory evaluations suggest cychlorphine could be roughly 10 times more potent than fentanyl, although medical experts caution that the estimate is derived from in-vitro pharmacology rather than controlled trials in humans. Dr. Shan Yin, a board member of the American College of Medical Toxicology, told Rolling Stone that while clinical human dosing data does not exist, pharmacologic models support the assumption that the drug is stronger than fentanyl.
Medical authorities emphasized that naloxone remains capable of counteracting cychlorphine overdoses. Because the compound binds to opioid receptors, the medication can reverse its respiratory effects, though severe exposures may require repeated doses and prompt medical intervention.
Public health agencies are continuing to track whether cychlorphine is establishing a broader presence in western drug markets or remaining an occasional additive in counterfeit supply chains.
